Skip to main content
OpenTrials

Clinical trial condition

Hematological Malignancies

Explore clinical trials studying Hematological Malignancies. Study availability and eligibility vary by location and protocol.

102 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Hematological Malignancies trial results

Completed

Pasireotide in Prevention of GI Toxicity

NCT02215070

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +22 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

NCT01830010

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Regensburg, Bavaria, Germany
  • Novartis Investigative Site Cologne, Germany
  • Novartis Investigative Site Freiburg im Breisgau, Germany
View Trial Details
Completed

Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM

NCT01816230

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +18 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Loyola University, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Steven and Alexandra Cohen Children's Medical Center New York, United States
View all 15 locations
View Trial Details

Related conditions